Literature DB >> 16456713

Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.

T W Loo1, D M Clarke.   

Abstract

P-glycoprotein (P-gp) is an ATP-dependent drug pump that can transport a broad range of hydrophobic compounds out of the cell. The protein is clinically important because of its contribution to the phenomenon of multidrug resistance during AIDS/HIV and cancer chemotherapy. P-gp is a member of the ATP-binding cassette (ABC) family of proteins. It is a single polypeptide that contains two repeats joined by a linker region. Each repeat has a transmembrane domain consisting of six transmembrane segments followed by a hydrophilic domain containing the nucleotide-binding domain. In this mini-review, we discuss recent progress in determining the structure and mechanism of human P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16456713     DOI: 10.1007/s00232-005-0792-1

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  147 in total

1.  Superfolding of the partially unfolded core-glycosylated intermediate of human P-glycoprotein into the mature enzyme is promoted by substrate-induced transmembrane domain interactions.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

2.  The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism.

Authors:  Kaspar P Locher; Allen T Lee; Douglas C Rees
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

3.  Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

4.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

Authors:  S Dey; M Ramachandra; I Pastan; M M Gottesman; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore.

Authors:  Zhi-Ren Zhang; Guiying Cui; Xuehong Liu; Binlin Song; David C Dawson; Nael A McCarty
Journal:  J Biol Chem       Date:  2004-10-25       Impact factor: 5.157

6.  Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  2001-06-27       Impact factor: 5.157

7.  Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.

Authors:  T W Loo; D M Clarke
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

8.  Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites.

Authors:  C A Hrycyna; M Ramachandra; S V Ambudkar; Y H Ko; P L Pedersen; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2004-01-28       Impact factor: 5.157

10.  Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  53 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

3.  Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.

Authors:  Camille Roucairol; Stéphane Azoulay; Marie-Claire Nevers; Christophe Créminon; Thibault Lavrut; Rodolphe Garraffo; Jacques Grassi; Alain Burger; Danièle Duval
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Additive effect of multiple pharmacological chaperones on maturation of CFTR processing mutants.

Authors:  Ying Wang; Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

5.  Using a cysteine-less mutant to provide insight into the structure and mechanism of CFTR.

Authors:  Tip W Loo; David M Clarke
Journal:  J Physiol       Date:  2006-02-23       Impact factor: 5.182

6.  Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.

Authors:  Shi Lu; Qi Huang; Zehua Wang; Yinfeng Song; Lijun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

7.  Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.

Authors:  Soichi Haraguchi; Sarah K Ho; Matthew Morrow; Maureen M Goodenow; John W Sleasman
Journal:  J Leukoc Biol       Date:  2011-04-19       Impact factor: 4.962

8.  A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.

Authors:  Matthew H Crouthamel; Daniel Wu; Ziping Yang; Rodney J Y Ho
Journal:  AAPS J       Date:  2010-07-10       Impact factor: 4.009

9.  In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.

Authors:  Mary Beth Dail; Edward Caldwell Meek; Howard Wayne Chambers; Janice Elaine Chambers
Journal:  Drug Chem Toxicol       Date:  2018-05-03       Impact factor: 3.356

10.  Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure.

Authors:  Aina W Ravna; Ingebrigt Sylte; Georg Sager
Journal:  Theor Biol Med Model       Date:  2009-09-04       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.